We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Review Casts Doubts on Benefits of Omega-3s

By Biotechdaily staff writers
Posted on 13 Apr 2006
A recent study contradicted the commonly held belief that enrichment of omega-3 fatty acids in the diet helps prevent both heart disease and cancer.

A simple search of the Internet readily produced information relating to the purported benefits of omega-3 fatty acids. More...
For example, one article stated that men who consumed one or more fish meals--rich in omega-3 fatty acids--per week had a 50% lower risk of developing sudden cardiac death than men who rarely ate fish (less than one fish meal per month). In a separate article, scientists compared blood levels of omega-3 fatty acids in 94 men who died of sudden cardiac death against living men matched for age and smoking habits. They found that high levels of omega-3 fatty acids in the blood were associated with a low risk of cardiac sudden death. Men with the highest blood levels of omega-3 fatty acids had an 80% lower risk of sudden cardiac death than men with the lowest blood levels.

In order to put findings regarding omega-3 fatty acids on a firm scientific base, investigators at the University of East Anglia (Norwich, UK) conducted a systematic review of the professional literature relating to the subject.

Their report published in the March 24, 2006, online edition of the British Medical Journal covered 15,159 titles and abstracts including 48 randomized controlled trials (36,913 participants) and 41 cohort studies.

Surprisingly, the reviewers found little evidence to support the beneficial effects of omega-3 fatty acids. No strong evidence of reduced risk of total mortality or combined cardiovascular events in participants taking additional omega-3 fats was actually reported. When data from a subgroup of studies of long chain omega-3 fats were analyzed separately, total mortality and cardiovascular events were not clearly reduced.

The authors concluded that, "Long chain and shorter chain omega-fats do not have a clear effect on total mortality, combined cardiovascular events, or cancer.” Nonetheless, it will require more high-quality randomized controlled trials of long duration before a final verdict on the benefits of omega-3 fatty acids can be rendered.




Related Links:
University of East Anglia

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.